Read More Biotech FDA General News OncoCyte Sponsored Study Titled ‘Prospective Trial to Define Outcomes of Patients With Completely Resected Stage I or IIA Non-squamous NSCLC Identified as High, Intermediate, or Low Risk’ Posted To ClinicalTrials.gov, Not Yet Recruiting By Benzinga Newsdesk Today, 9:40 AM https://clinicaltrials.gov/ct2/show/NCT05032352 OCX
Read More Education General News Don’t Try To Be A Leader For The Sake Of Being A Leader: Career Advice From Elon Musk By Chris Katje Today, 9:40 AM Elon Musk is the CEO of two companies valued at $100 billion or more and one of the most followed business leaders in the world. PYPL
Read More Analyst Color Analyst Ratings Biotech General Health Care Initiation News Price Target Mizuho Bolsters Price Target By 55% On This Migraine Stock By Vandana Singh Today, 9:40 AM Mizuho Securities assumes coverage of Axsome Therapeutics Inc (NASDAQ:AXSM), with a Buy rating and a price target of $76, representing a 25%… AXSM
Read More General News TELUS Partners With AWS For Smart Living Solutions By Shivani Kumaresan Today, 9:40 AM TELUS Corporation (NYSE:TU) is partnering with Amazon.Com, Inc. (NASDAQ:AMZN) Amazon Web Services Inc (AWS) to create a new TELUS smart living… AMZN